LATEST NEWS
Cipla Awarded US$189 Million Of Global Fund ARV Tender
Cipla has been selected by the Global Fund to produce anti-retroviral drugs for the next three years.
Antibody Treatment For Influenza
An antibody targeting the molecule ANGPTL4 could help influenza patients recover faster, study suggests.
Reversing Obesity’s Impact On Fertility
Drugs targeting the mitochondria could potentially be used to restore fertility to obese women, study suggests.
Asian Scientist’s Guide To Surviving Chinese New Year
It's not always easy, but Chinese new year and other festive occasions are actually a great opportunity to try out your science communication skills.
Stopping Inflammation-Related Cancers
Rather than inhibiting the expression of FAT-10, simply blocking its binding to MAD2 could help prevent tumor progression.
Eisai’s Thyroid Cancer Drug Gets US FDA Approval
A Phase III trial has shown that the drug Lenvima significantly improves the progression-free survival of thyroid cancer patients.
Myopia A Middle-Class Disease?
A study of 20,000 children shows that nearsightedness is twice as prevalent in middle-income areas than lower-income ones in China.
How Early Mammals Adapted In An Age Of Dinosaurs
Ancestral mammals survived by occupying niche environments such as trees and subterranean caves.
Fighting Cavities With Nanoparticles
Silicon nanoparticles soaked with disinfectants can inhibit bacterial growth for up to three days and could be used to prevent oral biofilm formation.
